Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gozewijn D Laverman

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Nursing Open|April 14, 2025
Implementing Lifestyle Counselling Into Secondary Type 2 Diabetes Care: Perspectives From Diabetes NursesChantal H M Pot, Eclaire A G Hietbrink, Gozewijn D Laverman
The Journal of Pathology|September 2, 2003
Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damageAndrea B Kramer, Gozewijn D Laverman, Harry van Goor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 13, 2003
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reductionLiffert Vogt, Gozewijn D Laverman, Robin P F Dullaart, et al.
Journal of Personalized Medicine|February 25, 2022
Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein IntakeMilou M Oosterwijk, Gerjan Navis, Stephan J L Bakker, et al.
Diabetes, Obesity & Metabolism|July 8, 2017
Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition?Sergei Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.
BMJ Open Diabetes Research & Care|February 26, 2025
Quantification of the relation between continuous glucose monitoring observation period and the estimation error in assessing long-term glucose regulationStennie Zoet, Thomas Urgert, Anouk Veldhuis, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patientsSergei I Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 28, 2014
Quiz page February 2014: swollen kidneys and a pancreatic massDinette E Agterhuis, Edwin P Schuurmans, Marieke C H Hogenes, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 28, 2022
Urinary creatinine excretion is an indicator of physical performance and functionMilou M Oosterwijk, Niala den Braber, Stephan J L Bakker, et al.
BMJ Open|December 3, 2024
Analysing physical activity measures and clustering in patients with type 2 diabetes in secondary care: insights from the DIAbetes and LifEstyle Cohort Twente (DIALECT)-an observational cohort studyNiala den Braber, Miriam M Vollenbroek-Hutten, Kilian D R Kappert, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Nursing Open|April 14, 2025
Implementing Lifestyle Counselling Into Secondary Type 2 Diabetes Care: Perspectives From Diabetes NursesChantal H M Pot, Eclaire A G Hietbrink, Gozewijn D Laverman
The Journal of Pathology|September 2, 2003
Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damageAndrea B Kramer, Gozewijn D Laverman, Harry van Goor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 13, 2003
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reductionLiffert Vogt, Gozewijn D Laverman, Robin P F Dullaart, et al.
Journal of Personalized Medicine|February 25, 2022
Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein IntakeMilou M Oosterwijk, Gerjan Navis, Stephan J L Bakker, et al.
Diabetes, Obesity & Metabolism|July 8, 2017
Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition?Sergei Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.
BMJ Open Diabetes Research & Care|February 26, 2025
Quantification of the relation between continuous glucose monitoring observation period and the estimation error in assessing long-term glucose regulationStennie Zoet, Thomas Urgert, Anouk Veldhuis, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patientsSergei I Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 28, 2014
Quiz page February 2014: swollen kidneys and a pancreatic massDinette E Agterhuis, Edwin P Schuurmans, Marieke C H Hogenes, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 28, 2022
Urinary creatinine excretion is an indicator of physical performance and functionMilou M Oosterwijk, Niala den Braber, Stephan J L Bakker, et al.
BMJ Open|December 3, 2024
Analysing physical activity measures and clustering in patients with type 2 diabetes in secondary care: insights from the DIAbetes and LifEstyle Cohort Twente (DIALECT)-an observational cohort studyNiala den Braber, Miriam M Vollenbroek-Hutten, Kilian D R Kappert, et al.
Pageof 11